Search results for "peripheral"

showing 10 items of 1028 documents

A muscarinic mechanism inhibiting the release of noradrenaline from peripheral adrenergic nerve fibres by nicotinic agents.

1968

SympathomimeticsMalemedicine.medical_specialtySympathetic nervous systemSympathetic Nervous SystemReceptors DrugGuinea PigsAdrenergicParasympathomimeticsPharmacologyPiperazinesNorepinephrine (medication)NorepinephrineHeart Conduction SystemInternal medicineMuscarinic acetylcholine receptormedicineAnimalsHeart AtriaSympathomimeticsDrug AntagonismChemistryGeneral MedicinePeripheralPerfusionmedicine.anatomical_structureEndocrinologyParasympathomimeticsFemaleRabbitsDrug Antagonismmedicine.drugResearch Article
researchProduct

Two-particle azimuthal correlations in photonuclear ultraperipheral Pb+Pb collisions at 5.02 TeV with ATLAS

2021

We thank CERN for the very successful operation of the LHC, as well as the support staff from our institutions without whom ATLAS could not be operated efficiently. We acknowledge the support of ANPCyT, Argentina, YerPhI, Armenia, ARC, Australia, BMWFW and FWF, Austria, ANAS, Azerbaijan, SSTC, Belarus, CNPq and FAPESP, Brazil, NSERC, NRC, and CFI, Canada, CERN and ANID, Chile, CAS, MOST, and NSFC, China, COLCIENCIAS, Colombia, MSMT CR, MPO CR, and VSC CR, Czech Republic, DNRF and DNSRC, Denmark, IN2P3-CNRS and CEA-DRF/IRFU, France, SRNSFG, Georgia, BMBF, HGF, and MPG, Germany, GSRT, Greece, RGC and Hong Kong SAR, China, ISF and Benoziyo Center, Israel, INFN, Italy, MEXT and JSPS, Japan, CNR…

Systemgap [rapidity]heavy ion: scattering:Kjerne- og elementærpartikkelfysikk: 431 [VDP]Performanceangular correlation: long-rangeHadronMonte Carlo method01 natural sciencesHigh Energy Physics - ExperimentSubatomär fysikHigh Energy Physics - Experiment (hep-ex)PpCollisionscorrelation function: two-particleSubatomic Physics[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Nuclear Experiment (nucl-ex)Nuclear ExperimentNuclear Experimentcalorimeter: forward spectrometerSettore FIS/01Physicsangular correlation: two-particletwo-particle [correlation function]Large Hadron Collider4. EducationATLAS experimentHeavy-Ion CollisionsMonte Carlo [numerical calculations]ATLASCalorimeterforward spectrometer [calorimeter]CERN LHC Coll:Nuclear and elementary particle physics: 431 [VDP]medicine.anatomical_structureMultiplicityflowPseudorapidityDistributionsLhcnumerical calculations: Monte CarloParticle Physics - Experimentcharged particle: tracks530 PhysicscollectiveFOS: Physical sciencesLHC ATLAS High Energy Physicstransverse momentum[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]Relativistic heavy ionscharged particle: multiplicityNuclear physicsmultiplicity [charged particle]scattering [heavy ion]Atlas (anatomy)long-range [angular correlation]0103 physical sciencesmedicineFluctuationsNuclear Physics - Experimentddc:5305020 GeV-cms/nucleonHigh Energy Physicsperipheral010306 general physicshadron hadron: interactioninteraction [hadron hadron]LHC; Particle Physics; Photonuclear interactionstwo-particle [angular correlation]tracks [charged particle]010308 nuclear & particles physicsFísicaDetectorMultiplicity (mathematics)boundary conditionrapidity: gapcorrelationExperimental High Energy Physicsexperimental resultsModelPhysical Review C
researchProduct

How to manage patients with polyvascular atherosclerotic disease. Position paper of the International Union of Angiology

2020

Atherosclerosis is a systemic disease affecting multiple arterial territories. Patients with clinical atherosclerotic disease in one vascular bed are likely to have asymptomatic or symptomatic atherosclerotic lesions in other vascular beds. Specifically, peripheral arterial disease (PAD) often coexists with coronary and carotid disease. With progression of atherosclerotic disease in one vascular bed, the risk of clinical manifestations in other territories increases and the incidence of adverse cardiovascular events increases substantially with the number of affected vascular beds. Classical risk factors are associated with the development of polyvascular atherosclerotic disease (PVD) in di…

Systemic diseasemedicine.medical_specialtymedicine.medical_treatmentCardiologyDisease030204 cardiovascular system & hematology030230 surgeryRevascularizationAsymptomaticPeripheral Arterial Disease03 medical and health sciences0302 clinical medicineRisk FactorsmedicineHumansIntensive care medicineAngiologybusiness.industryIncidence (epidemiology)GuidelineAtherosclerosismedicine.diseasePosition papermedicine.symptomCardiology and Cardiovascular MedicinebusinessInternational Angiology
researchProduct

Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2020

Abstract: Background Health system planning requires careful assessment of chronic kidney disease (CKD) epidemiology, but data for morbidity and mortality of this disease are scarce or non-existent in many countries. We estimated the global, regional, and national burden of CKD, as well as the burden of cardiovascular disease and gout attributable to impaired kidney function, for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. We use the term CKD to refer to the morbidity and mortality that can be directly attributed to all stages of CKD, and we use the term impaired kidney function to refer to the additional risk of CKD from cardiovascular disease and gout. Methods Th…

Systems AnalysisGoutCost effectiveness030204 cardiovascular system & hematologyGlobal HealthGLOMERULAR-FILTRATION-RATEGlobal Burden of DiseaseCOST-EFFECTIVENESS0302 clinical medicineCause of DeathPrevalenceGlobal healthDiabetic NephropathiesRegistries030212 general & internal medicineSUB-SAHARAN AFRICA11 Medical and Health SciencesIncidenceMortality rate1. No povertyGeneral MedicineHälsovetenskaperGBD Chronic Kidney Disease CollaborationCKD-EPI EQUATION3. Good healthEuropeCardiovascular Diseases/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingQuality-Adjusted Life YearsLife Sciences & BiomedicineAsiaOceania195 COUNTRIESATHEROSCLEROSIS RISKCARDIOVASCULAR OUTCOMESRisk AssessmentArticle03 medical and health sciencesMedicine General & InternalSDG 3 - Good Health and Well-beingRISK-FACTORGeneral & Internal MedicineEnvironmental healthHealth SciencesmedicineHumansGBD chronic kidney diseaseMortalityRisk factorRenal Insufficiency ChronicDisease burdenQMScience & TechnologyAustralasiabusiness.industryPERIPHERAL ARTERIAL-DISEASEBayes Theoremmedicine.diseaseHealth SurveysQuality-adjusted life yearRENAL-DISEASELatin AmericaYears of potential life lostAfricaNorth AmericaHuman medicinebusinessRCKidney disease
researchProduct

Peripheral T-cell lymphoma classification: the matter of cellular derivation.

2011

Peripheral T-cell lymphomas (PTCLs) represent approximately 12% of all non-Hodgkin's lymphomas in Western countries. They are quite heterogeneous as far as morphology and phenotype are concerned. Furthermore, until now, PTCLs could not be referred to specific normal counterparts, in contrast to B-cell-derived non-Hodgkin's lymphomas. In particular, in the last edition of the WHO classification of Tumors of the Hematopoietic and Lymphoid Tissues, for the majority of nodal PTCLs (including the not otherwise specified type and anaplastic large-cell lymphoma), the postulated cell of origin remained undefined. However, in the last few years, high-throughput genomic techniques, especially gene-ex…

T cellGene Expression ProfilingNot Otherwise SpecifiedT lymphocytesLymphoma T-Cell PeripheralTfhHematologyBiologymedicine.diseasePhenotypePeripheral T-cell lymphomaLymphomaGene expression profilingcytotoxicgene-expression profilemedicine.anatomical_structureImmunologymedicineCancer researchCytotoxic T cellHumansProspective Studiesperipheral T-cell lymphomaTumors of the hematopoietic and lymphoid tissuesExpert review of hematology
researchProduct

Immature, but not inactive: the tolerogenic function of immature dendritic cells.

2002

The induction of antigen-specific T cell tolerance and its maintenance in the periphery is critical for the prevention of autoimmunity. Recent evidence shows that dendritic cells (DC) not only initiate T cell responses, but are also involved in silencing of T cell immune responses. The functional activities of DC are mainly dependent on their state of activation and differentiation, that is, terminally differentiated mature DC can efficiently induce the development of T effector cells, whereas immature DC are involved in maintenance of peripheral tolerance. The means by which immature DC maintain peripheral tolerance are not entirely clear, however, their functions include the induction of …

T cellImmunologyAntigen presentationClonal DeletionAutoimmunityBiologyAutoantigensClonal deletionMiceImmune systemCell MovementT-Lymphocyte SubsetsmedicineImmune ToleranceImmunology and AllergyCytotoxic T cellAnimalsHumansIL-2 receptorAntigen-presenting cellAntigen PresentationImmunity CellularModels ImmunologicalPeripheral toleranceCell BiologyDendritic CellsCell biologymedicine.anatomical_structureOrgan SpecificityImmunologyImmunology and cell biology
researchProduct

Sources and functional significance of IL-6 in shaping autoreactive T cell responses in the peripheral immune compartment and the CNS

2014

T cellImmunologyCompartment (chemistry)BiologyPeripheralmedicine.anatomical_structureImmune systemNeurologyImmunologymedicinebiology.proteinImmunology and AllergyFunctional significanceNeurology (clinical)Interleukin 6Journal of Neuroimmunology
researchProduct

Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial

2000

The ELISPOT assay is increasingly being used for the monitoring of the induction of antigen-reactive T cells in cancer vaccination trials. In order to evaluate the reliability of T cell frequency analysis with the ELISPOT assay, a comparative study was performed in four European laboratories. Six samples from healthy subjects were analyzed for the frequency of influenza-reactive CD8+ T cells in peripheral blood mononuclear cells (PBMC) by IFNgamma-ELISPOT assay. In addition, one laboratory determined cytotoxic T cell precursor (CTL) frequencies in these samples by limiting dilution chromium-release assay (LDA), and three laboratories performed a variant of the LDA, the multiple microculture…

T cellImmunologyEpitopes T-LymphocyteIndicator Dilution TechniquesEnzyme-Linked Immunosorbent AssayCD8-Positive T-LymphocytesLymphocyte ActivationPeripheral blood mononuclear cellViral Matrix ProteinsInterferon-gammaAntigenHLA-A2 AntigenHumansImmunology and AllergyCytotoxic T cellMedicineAntigens ViralImmunodominant Epitopesbusiness.industryELISPOTMolecular biologyChromium RadioisotopesHIV Reverse TranscriptasePeptide FragmentsCTL*medicine.anatomical_structureImmunologyLeukocytes MononuclearCancer vaccinebusinessCD8T-Lymphocytes Cytotoxic
researchProduct

HLA-DR phenotypes and blood levels of T cell subsets

1984

Blood mononuclear cell and T cell subsets values were analyzed in 53 Sicilian individuals according to HLA-DR phenotypes. The results demonstrate that DR1-positive subjects show a significant increase of blood T cell subsets whereas DR3-positive subjects show a non-significant decrease of these values. These results suggest that gene(s) associated with HLA-DR could be one of the factors which affect blood levels of T cell subsets.

T-LymphocytesT cellImmunologyHLA-DR1 AntigenHistocompatibility Antigens Class IIHLA-DR AntigensGeneral MedicineImmunogeneticsT lymphocyteBiologyBiochemistryPhenotypePeripheral blood mononuclear cellLeukocyte CountHLA-DR3 AntigenPhenotypemedicine.anatomical_structureImmunologyGeneticsmedicineHLA-DRHumansImmunology and AllergyGeneTissue Antigens
researchProduct

Effects of chronic administration with high doses of testosterone propionate on behavioral and physiological parameters in mice with differing basal …

2003

The effects of testosterone propionate, an anabolic-androgenic steroid, on the behavior displayed during a social encounter by gonadally intact male mice were investigated. Animals were distributed into three groups according to their attack latency in a pre-screening test (high-, moderate-, and low-attacking mice) and each group received weekly injections of 60 or 120 mg/kg of testosterone or sesame oil for 10 weeks. Behavioral tests were then carried out. Afterwards, organs were weighed and blood samples collected in order to obtain hormonal data. Treatment had a differential impact on attack in the three groups of animals. Only the high-attacking testosterone-treated mice showed lower to…

Testosterone propionatemedicine.medical_specialtyAnabolismmedicine.medical_treatmentPoison controlPeripheralSteroidchemistry.chemical_compoundEndocrinologyArts and Humanities (miscellaneous)chemistryInternal medicineDevelopmental and Educational PsychologymedicineHigh dosesSocial encounterPsychologyGeneral PsychologyHormoneAggressive Behavior
researchProduct